MedikitLtd 관리

관리 기준 확인 2/4

MedikitLtd CEO는 Yoji Kageyama, Jun2021 에 임명되었습니다 의 임기는 3.42 년입니다. 는 ¥ 58.44M 가치에 해당하는 회사 주식의 0.14% 직접 소유합니다. 58.44M. 경영진과 이사회의 평균 재임 기간은 각각 4.4 년과 9.4 년입니다.

주요 정보

Yoji Kageyama

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	3.4yrs
CEO 소유권	0.1%
경영진 평균 재임 기간	4.4yrs
이사회 평균 재임 기간	9.4yrs

최근 관리 업데이트

Recent updates

Update: MedikitLtd (TYO:7749) Stock Gained 79% In The Last Five Years

Mar 12

Is MedikitLtd (TYO:7749) Likely To Turn Things Around?

Feb 22

Has Medikit Co.,Ltd. (TYO:7749) Stock's Recent Performance Got Anything to Do With Its Financial Health?

Feb 02

CEO

Yoji Kageyama (64 yo)

3.4yrs

테뉴어

Mr. Yoji Kageyama is President & Representative Director of Medikit Co.,Ltd. from June 2021. He joined the Medikit Co.,Ltd.in May 1986. He was MD of Sales Department, East Japan Overseas Business Division...

리더십 팀

이름	위치	테뉴어	보상	소유권
Hiroaki Nakajima	Founder	no data	JP¥131.10m	데이터 없음
Yoji Kageyama	President & Representative Director	3.4yrs	데이터 없음	0.14% ¥ 58.4m
Takashi Nakajima	Executive VP of Administration Division & Director	3.4yrs	데이터 없음	5.72% ¥ 2.3b
Hiroshi Horinouchi	Sales Administration Department & Director	10.2yrs	데이터 없음	0.066% ¥ 26.8m
Fumihiro Nakajima	Director & Director of Corporate Planning	5.4yrs	데이터 없음	0.022% ¥ 8.7m

4.4yrs

평균 재임 기간

64yo

평균 연령

경험이 풍부한 관리: 7749 의 관리팀은 경험 ( 4.4 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Yoji Kageyama	President & Representative Director	15.4yrs	데이터 없음	0.14% ¥ 58.4m
Takashi Nakajima	Executive VP of Administration Division & Director	14.4yrs	데이터 없음	5.72% ¥ 2.3b
Hiroshi Horinouchi	Sales Administration Department & Director	9.4yrs	데이터 없음	0.066% ¥ 26.8m
Fumihiro Nakajima	Director & Director of Corporate Planning	5.4yrs	데이터 없음	0.022% ¥ 8.7m
Yasuyuki Yoshida	Independent External Director	9.4yrs	데이터 없음	0.0027% ¥ 1.1m
Shuji Oshima	External Auditor	10.4yrs	데이터 없음	데이터 없음
Atsuko Otaki	Independent Outside Director	3.4yrs	데이터 없음	데이터 없음
Fukuichi Yoshida	Outside Corporate Auditor	3.4yrs	데이터 없음	데이터 없음
Naomichi Kaneko	Full Time Auditor	7.4yrs	데이터 없음	0.054% ¥ 21.8m

9.4yrs

평균 재임 기간

64yo

평균 연령

경험이 풍부한 이사회: 7749 의 이사회는 경험(평균 재직 기간 9.4 년)으로 간주됩니다.

MedikitLtd 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Medikit Co.,Ltd., Annual General Meeting, Jun 26, 2024

Medikit Co.,Ltd., Annual General Meeting, Jun 28, 2023

Less than half of directors are independent

Medikit Co.,Ltd., Annual General Meeting, Jun 29, 2022

Less than half of directors are independent

Recent updates

Second quarter 2025 earnings released: EPS: JP¥58.96 (vs JP¥45.02 in 2Q 2024)

Medikit Co.,Ltd. (TSE:7749) announces an Equity Buyback for 250,000 shares, representing 1.69% for ¥711.75 million.

Upcoming dividend of JP¥45.00 per share

Medikit Co.,Ltd. to Report Q2, 2025 Results on Nov 11, 2024

First quarter 2025 earnings released: EPS: JP¥27.37 (vs JP¥33.60 in 1Q 2024)

Medikit Co.,Ltd. to Report Q1, 2025 Results on Aug 09, 2024

Full year 2024 earnings released: EPS: JP¥188 (vs JP¥171 in FY 2023)

Medikit Co.,Ltd., Annual General Meeting, Jun 26, 2024

Upcoming dividend of JP¥35.00 per share

Medikit Co.,Ltd. to Report Fiscal Year 2024 Results on May 15, 2024

Third quarter 2024 earnings released: EPS: JP¥48.29 (vs JP¥55.53 in 3Q 2023)

Medikit Co.,Ltd. (TSE:7749) announces an Equity Buyback for 2,200,100 shares, representing 13.1% for ¥5,253.84 million.

Medikit Co.,Ltd. to Report Q3, 2024 Results on Feb 09, 2024

Second quarter 2024 earnings released: EPS: JP¥45.01 (vs JP¥39.26 in 2Q 2023)

Upcoming dividend of JP¥35.00 per share at 2.6% yield

Medikit Co.,Ltd. to Report Q2, 2024 Results on Nov 10, 2023

First quarter 2024 earnings released: EPS: JP¥33.60 (vs JP¥32.01 in 1Q 2023)

Medikit Co.,Ltd. to Report Q1, 2024 Results on Aug 10, 2023

Medikit Co.,Ltd., Annual General Meeting, Jun 28, 2023

Full year 2023 earnings released: EPS: JP¥171 (vs JP¥178 in FY 2022)

Upcoming dividend of JP¥30.00 per share at 2.5% yield

Third quarter 2023 earnings released: EPS: JP¥55.52 (vs JP¥45.28 in 3Q 2022)

Medikit Co.,Ltd. to Report Q3, 2023 Results on Feb 10, 2023

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: JP¥39.26 (vs JP¥43.14 in 2Q 2022)

Medikit Co.,Ltd. to Report Q2, 2023 Results on Nov 11, 2022

First quarter 2023 earnings released: EPS: JP¥32.01 (vs JP¥40.17 in 1Q 2022)

Medikit Co.,Ltd. to Report Q1, 2023 Results on Aug 10, 2022

Full year 2022 earnings released: EPS: JP¥178 (vs JP¥157 in FY 2021)

Medikit Co.,Ltd., Annual General Meeting, Jun 29, 2022

Less than half of directors are independent

Medikit Co.,Ltd. to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥50.00 per share

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Medikit Co.,Ltd. (JASDAQ:7749) announces an Equity Buyback for 144,000 shares, representing 0.86% for ¥400 million.

Second quarter 2022 earnings released: EPS JP¥43.14 (vs JP¥34.21 in 2Q 2021)

Full year 2021 earnings released: EPS JP¥157 (vs JP¥170 in FY 2020)

Upcoming dividend of JP¥50.00 per share

Update: MedikitLtd (TYO:7749) Stock Gained 79% In The Last Five Years

Medikit Co.,Ltd. to Report Fiscal Year 2021 Results on May 14, 2021

Is MedikitLtd (TYO:7749) Likely To Turn Things Around?

Third quarter 2021 earnings released: EPS JP¥46.43 (vs JP¥48.84 in 3Q 2020)

Has Medikit Co.,Ltd. (TYO:7749) Stock's Recent Performance Got Anything to Do With Its Financial Health?

Is Medikit Co.,Ltd. (TYO:7749) A Smart Choice For Dividend Investors?

Is Medikit Co.,Ltd.'s (TYO:7749) Shareholder Ownership Skewed Towards Insiders?

Investors Who Bought MedikitLtd (TYO:7749) Shares Five Years Ago Are Now Up 80%

Medikit Co.,Ltd. to Report Q3, 2021 Results on Feb 10, 2021

New 90-day low: JP¥2,950

Second quarter 2021 earnings released: EPS JP¥34.21

New 90-day low: JP¥3,015

New 90-day low: JP¥3,085

Medikit Co.,Ltd. to Report Q2, 2021 Results on Nov 12, 2020

New 90-day low - JP¥3,330

Earnings released

CEO

테뉴어

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령